According to a report from the Sunday Telegraph, the UK will begin rolling out the Oxford University’s COVID-19 vaccine from January 4.

The first dose of the Oxford vaccine, which has been licensed to AstraZeneca, or that of Pfizer-BioNTech’s, will be given to 2 million people over course of the next two weeks, said the report.

The Oxford vaccine is scheduled to be approved by UK’s medical regulators in the coming days.

Categories: Creativity, Economy & Finance, Entrepreneurship, HR & Organization, Regulations & Legal, Strategy, Sustainability

Tags: AstraZeneca, Britain, COVID-19, COVID19, inoculate, inoculation, licensed to, medical regulators, Oxford University, Pfizer BioNTech, UK, United Kingdom, vaccine